Nephros (NEPH) Total Debt Growth (1y) (2017 - 2022)
Powered by 
Analysis
Nephros (NEPH) Total Debt Growth (1y) (2017 - 2022) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | 142.67% |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | - |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | -1.59% |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | -9.88% |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | 8.95% |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | 0.12% |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | -9.07% |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | - |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | 12.29% |
| 10 | Nephros | 48.31 Mn | 43.62 Mn | 4.03 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | -50.15% |
| Sep 30, 2022 | -65.36% |
| Jun 30, 2022 | -12.77% |
| Mar 31, 2022 | -47.93% |
| Dec 31, 2021 | -51.76% |
| Sep 30, 2021 | -47.01% |
| Jun 30, 2021 | -38.88% |
| Mar 31, 2021 | -49.24% |
| Dec 31, 2020 | -39.39% |
| Sep 30, 2020 | -53.57% |
| Jun 30, 2020 | -56.08% |
| Mar 31, 2020 | -38.10% |
| Dec 31, 2019 | -36.04% |
| Sep 30, 2019 | 52.02% |
| Jun 30, 2019 | 53.87% |
| Mar 31, 2019 | 42.63% |
| Dec 31, 2018 | 10.15% |
| Sep 30, 2018 | 18.00% |
| Jun 30, 2018 | 27.58% |
| Mar 31, 2018 | 37.38% |